Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Bionomics.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Surely we’ve all completely lost interest in talking about interest rates by now
News
ASX Small Caps Lunch Wrap: Who else is suffering from projectile dysfunction today?
Health & Biotech
Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half
Health & Biotech
ASX Health Stocks: Respiri expands footprints to New Mexico; Bionomics has a new CEO
News
LAST ORDERS: One man’s titanic struggle to make sense of even the simplest things today.
Health & Biotech
HealthKick Podcast: Bionomic charges forward with lead drug candidate treatment for PTSD and social anxiety
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
News
Trading Places: Base metals stocks were popular, while investors snapped up Afterpay before it left the ASX
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Virtus is being pursued as Bionomics prepares for dual Nasdaq listing
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: Apiam and Trajan on acquisition trail, Immutep provides updates on Phase 2 trials
Health & Biotech
ASX Health Stocks: Zelira shares jump on $4m cannabis distribution deal to Germany
Health & Biotech
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
News
Market highlights and 5 ASX small caps to watch on Monday
News
